Regenerative Medicine Market by Therapy (Cell Therapy, Tissue Engineering, Immunotherapy, Gene Therapy), Product (Cell-Based, Acellular), Applications (Orthopedic & Musculoskeletal Disorders, Dermatology, Oncology, Cardiology) - Forecast to 2021

• INTRODUCTION
  • OBJECTIVES OF THE STUDY
  • MARKET DEFINITION
  • MARKET SCOPE
    • MARKETS COVERED
    • YEARS CONSIDERED FOR THE STUDY
  • CURRENCY
  • LIMITATIONS
  • STAKEHOLDERS
• RESEARCH METHODOLOGY
  • MARKET SIZE ESTIMATION
  • MARKET BREAKDOWN AND DATA TRIANGULATION
  • MARKET SHARE ESTIMATION
    • KEY DATA FROM SECONDARY SOURCES
    • KEY DATA FROM PRIMARY SOURCES
    • ASSUMPTIONS FOR THE STUDY
• EXECUTIVE SUMMARY
• PREMIUM INSIGHTS
  • REGENERATIVE MEDICINE: MARKET OVERVIEW
  • GEOGRAPHIC ANALYSIS: REGENERATIVE MEDICINE MARKET, BY THERAPY, 2016
  • GEOGRAPHICAL SNAPSHOT OF THE REGENERATIVE MEDICINE MARKET
• MARKET OVERVIEW
  • INTRODUCTION
  • MARKET DYNAMICS
  • DRIVERS
    • GOVERNMENT & PRIVATE FUNDING TO SUPPORT THE DEVELOPMENT OF REGENERATIVE MEDICINE
    • RISING PREVALENCE OF CHRONIC DISEASES AND GENETIC DISORDERS
    • INCREASE IN GLOBAL HEALTHCARE EXPENDITURE
    • RAPID GROWTH IN THE AGING POPULATION
    • INCREASE IN CORPORATE PARTNERSHIPS TO ACCELERATE DEVELOPMENT AND COMMERCIALIZATION OF REGENERATIVE MEDICINE
      • Table KEY CORPORATE PARTNERSHIPS, 2016
  • RESTRAINTS
    • ETHICAL CONCERNS WITH THE USE OF EMBRYONIC STEM CELL FOR R&D
    • LACK OF CLEAR REGULATORY GUIDELINES
  • OPPORTUNITIES
    • RISING DEMAND FOR ORGAN TRANSPLANTATION
    • STRONG PRODUCT PIPELINE
      • Table GENE THERAPY PRODUCTS IN CLINICAL TRIALS, 2016
      • Table CELL AND GENE THERAPY CLINICAL PRODUCT PIPELINE, 2016
• GLOBAL REGENERATIVE MEDICINE MARKET, BY PRODUCT
  • INTRODUCTION
    • Table GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
  • CELL-BASED PRODUCTS
    • Table CELL-BASED PRODUCTS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
    • Table CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
    • ALLOGENEIC PRODUCTS
      • Table ALLOGENEIC PRODUCTS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
    • AUTOLOGOUS PRODUCTS
      • Table AUTOLOGOUS PRODUCTS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • ACELLULAR PRODUCTS
    • Table ACELLULAR PRODUCTS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
• GLOBAL REGENERATIVE MEDICINE MARKET, BY THERAPY
  • INTRODUCTION
    • Table GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY, 2014-2021 (USD BILLION)
  • CELL THERAPY
    • Table STEM CELL THERAPIES IN PHASE III DEVELOPMENT, 2016
    • Table CELL THERAPY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TISSUE ENGINEERING
    • Table TISSUE ENGINEERING MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • IMMUNOTHERAPY
    • Table IMMUNOTHERAPY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • GENE THERAPY
    • Table GENE THERAPIES IN CLINICAL TRIALS, 2016
    • Table GENE THERAPY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
• REGENERATIVE MEDICINE MARKET, BY APPLICATION
  • INTRODUCTION
    • Table NUMBER OF CLINICAL TRIALS FOR REGENERATIVE MEDICINE, BY THERAPEUTIC CATEGORY (2016)
    • Table NUMBER OF CLINICAL TRIALS FOR REGENERATIVE MEDICINE, BY PHASE (2016)
    • Table REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
  • ORTHOPEDIC & MUSCULOSKELETAL DISORDERS
    • Table ORTHOPEDIC & MUSCULOSKELETAL DISORDERS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • DERMATOLOGY
    • Table DERMATOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • CARDIOLOGY
    • Table CARDIOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • CENTRAL NERVOUS SYSTEM DISEASES
    • Table CENTRAL NERVOUS SYSTEM DISEASES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • ONCOLOGY
    • Table CANCER PATIENTS (GLOBAL), BY CANCER TYPE, 2015-2035
    • Table ONCOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • DIABETES
    • Table DIABETES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • OTHER APPLICATIONS
    • Table OTHER APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
• GLOBAL REGENERATIVE MEDICINE MARKET, BY REGION
  • INTRODUCTION
    • Table GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • NORTH AMERICA
    • Table NORTH AMERICA: REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
    • Table NORTH AMERICA: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
    • Table NORTH AMERICA: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
    • Table NORTH AMERICA: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
    • Table NORTH AMERICA: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY, 2014-2021 (USD BILLION)
    • U.S.
      • Table U.S.: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
      • Table U.S.: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
      • Table U.S.: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
      • Table U.S.: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY, 2014-2021 (USD BILLION)
    • CANADA
      • Table CANADA: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
      • Table CANADA: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
      • Table CANADA: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
      • Table CANADA: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY, 2014-2021 (USD BILLION)
  • EUROPE
    • Table EUROPE: REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
    • Table EUROPE: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
    • Table EUROPE: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
    • Table EUROPE: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
    • Table EUROPE: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY, 2014-2021 (USD BILLION)
    • GERMANY
      • Table GERMANY: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
      • Table GERMANY: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
      • Table GERMANY: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
      • Table GERMANY: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY, 2014-2021 (USD BILLION)
    • U.K.
      • Table U.K.: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
      • Table U.K.: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
      • Table U.K.: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
      • Table U.K.: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY, 2014-2021 (USD BILLION)
    • FRANCE
      • Table FRANCE: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
      • Table FRANCE: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
      • Table FRANCE: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
      • Table FRANCE: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY, 2014-2021 (USD BILLION)
    • ITALY
      • Table ITALY: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
      • Table ITALY: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
      • Table ITALY: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
      • Table ITALY: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY, 2014-2021 (USD BILLION)
    • SPAIN
      • Table SPAIN: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
      • Table SPAIN: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
      • Table SPAIN: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
      • Table SPAIN: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY, 2014-2021 (USD BILLION)
    • REST OF EUROPE (ROE)
      • Table ROE: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
      • Table ROE: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
      • Table ROE: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
      • Table ROE: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY, 2014-2021 (USD BILLION)
  • ASIA-PACIFIC
    • Table ASIA-PACIFIC: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
    • Table ASIA: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
    • Table ASIA-PACIFIC: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
    • Table ASIA-PACIFIC: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY, 2013-2021 (USD BILLION)
  • REST OF THE WORLD (ROW)
    • Table ROW: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
    • Table ROW: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
    • Table ROW: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
    • Table ROW: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY, 2014-2021 (USD BILLION)
• COMPETITIVE LANDSCAPE
  • OVERVIEW
  • MARKET RANKING
    • Table RANKING OF MAJOR PLAYERS IN THE GLOBAL CELL-BASED REGENERATIVE MEDICINE MARKET (2015)
    • Table RANKING OF MAJOR PLAYERS IN THE GLOBAL ACELLULAR REGENERATIVE MEDICINE MARKET (2015)
    • Table KEY PRODUCTS IN THE CELL-BASED REGENERATIVE MEDICINE MARKET (2015)
    • Table KEY PRODUCTS IN THE ACELLULAR REGENERATIVE MEDICINE MARKET (2015)
  • COMPETITIVE SITUATION AND TRENDS
    • ACQUISITIONS
      • Table ACQUISITIONS, 2014-2017
    • PARTNERSHIPS
      • Table PARTNERSHIPS, 2014-2016
    • REGULATORY APPROVALS
      • Table REGULATORY APPROVALS, 2014-2016
    • NEW PRODUCT DEVELOPMENTS
      • Table NEW PRODUCT DEVELOPMENTS, 2013-2016
    • OTHERS
      • Table OTHERS, 2014-2016
• COMPANY PROFILES
  • ACELITY L.P. INC. (KCI LICENSING)
    • BUSINESS OVERVIEW
    • PRODUCTS OFFERED
    • RECENT DEVELOPMENTS
    • MNM VIEW
  • NUVASIVE, INC.
    • BUSINESS OVERVIEW
    • PRODUCTS OFFERED
    • RECENT DEVELOPMENTS
  • VERICEL CORPORATION
    • BUSINESS OVERVIEW
    • PRODUCTS OFFERED
    • RECENT DEVELOPMENTS
  • OSIRIS THERAPEUTICS, INC.
    • BUSINESS OVERVIEW
    • PRODUCTS OFFERED
    • RECENT DEVELOPMENTS
    • MNM VIEW
  • INTEGRA LIFESCIENCES CORPORATION
    • BUSINESS OVERVIEW
    • PRODUCTS OFFERED
    • RECENT DEVELOPMENTS
    • MNM VIEW
  • STRYKER CORPORATION
    • BUSINESS OVERVIEW
    • STRYKER CORPORATION: COMPANY SNAPSHOT (2015)
    • PRODUCTS OFFERED
    • RECENT DEVELOPMENTS
  • MEDTRONIC PLC
    • BUSINESS OVERVIEW
    • PRODUCTS OFFERED
    • RECENT DEVELOPMENTS
    • MNM VIEW
  • COOK BIOTECH INCORPORATED
    • PRODUCTS/SERVICES OFFERED
    • RECENT DEVELOPMENTS
  • ORGANOGENESIS INC.
    • BUSINESS OVERVIEW
    • PRODUCTS OFFERED
    • RECENT DEVELOPMENTS
    • MNM VIEW
  • JAPAN TISSUE ENGINEERING CO., LTD. (SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION)
    • BUSINESS OVERVIEW
    • PRODUCTS OFFERED
    • RECENT DEVELOPMENTS
• APPENDIX
  • INSIGHTS FROM INDUSTRY EXPERTS
  • DISCUSSION GUIDE
  • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • AVAILABLE CUSTOMIZATIONS
  • RELATED REPORTS
  • AUTHOR DETAILS

Regenerative Medicine Market by Therapy (Cell Therapy, Tissue Engineering, Immunotherapy, Gene Therapy), Product (Cell-Based, Acellular), Applications (Orthopedic & Musculoskeletal Disorders, Dermatology, Oncology, Cardiology) - Forecast to 2021

“Regenerative Medicine Market by Therapy (Cell Therapy, Tissue Engineering, Immunotherapy, Gene Therapy), By Product (Cell-Based, Acellular), By Applications (Orthopedic & Musculoskeletal Disorders, Dermatology, Oncology, Cardiology)-Forecast To 2021”

The global Regenerative medicine market is expected to reach USD 38.70 billion by 2021 from USD 13.41 billion in 2016 at a CAGR of 23.6% from 2016 to 2021

The major factor driving the growth of regenerative medicine market, are government and private funding to support the development of regenerative medicine, rising prevalence of chronic diseases and genetic disorders, increase in global healthcare expenditure, and rapid growth in the aging population.

The global Regenerative medicine market is segmented based on type, therapy, application, and regions. The cell-based products segment is expected to register to have largest market share in the Regenerative medicine market, by type, during the forecast period. The high growth in this segment is attributed to the increasing awareness about stem cell therapy, growing funding for new stem cell lines, and development of advanced genomic methods.

On the basis of therapy, the cell therapy procedure is expected to account for the largest share of the market in 2016. Increasing funding from several agencies and private organizations for the research and development of cell therapies, growing inclination of the healthcare industry towards stem cell research, and increasing global awareness about the benefits of stem cell therapies will drive the growth of this market.

On the basis of applications, the segments are orthopedic & musculoskeletal disorders, dermatology, cardiology, diabetes, central nervous system diseases, and other applications. Oncology is the fastest growing application market. Increasing cancer incidence, rich product pipeline and increasing demand for cancer treatments fuelling the growth of the market.

Geographically, the Regenerative medicine market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by rapidly increasing aging population and increase in chronic diseases are the major drivers for developed economies like the U.S.

The key players in the cell-based products segment are Organogenesis Inc. (U.S.), Osiris Therapeutics, Inc. (U.S.), Vericel Corporation (U.S.), Stryker Corporation (U.S.), and NuVasive, Inc. (U.S.). The key players in the acellular products segment are Medtronic (Ireland), Acelity (KCI Concepts) (U.S.), Integra LifeSciences (U.S.), Cook Biotech Inc. (U.S.), and C.R. Bard (U.S.).

Research Coverage:
The report analyses the Regenerative medicine market by type, therapy, application and regions. Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the Regenerative medicine market.

Reasons to Buy the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios of the top players in the Regenerative medicine market.
Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the Regenerative medicine market
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the Regenerative medicine market
Market Development: Comprehensive information about emerging markets. This report analyses the market for various Regenerative medicine market products across geographies
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Regenerative medicine market.